Assembly Biosciences ASMB Increase Decrease In Operating Lease Liabilities
Increase Decrease In Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept asmb:IncreaseDecreaseInOperatingLeaseLiabilities.
The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Assembly Biosciences's increase decrease in operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Assembly Biosciences's increase decrease in operating lease liabilities?
- Assembly Biosciences (ASMB) reported increase decrease in operating lease liabilities of -$202K in Q1 2026.
- How has Assembly Biosciences's increase decrease in operating lease liabilities changed year-over-year?
- Assembly Biosciences's increase decrease in operating lease liabilities decreased by 38.4% year-over-year, from -$146K to -$202K.
- What is the long-term trend for Assembly Biosciences's increase decrease in operating lease liabilities?
- Over 4 years (2021 to 2025), Assembly Biosciences's increase decrease in operating lease liabilities has grown at a -33.3% compound annual growth rate (CAGR), from -$3.79M to -$751K.
- What does increase decrease in operating lease liabilities mean?
- This measures the net change in the company's operating lease obligations during the period, reflecting cash payments made against lease liabilities. It helps investors understand the cash impact of the company's real estate and equipment leasing commitments. A decrease typically signifies cash outflows used to satisfy lease obligations.